Neuroendocrinology
Original Paper
Effect of the Antiandrogen Flutamide on Pituitary LH Content and ReleaseSardañons M.L.a · de las Heras M.A.b · Calandra R.S.b · Solano A.R.a · Podestá E.J.aaCentro de Investigaciones Endocrinológicas, Hospital de Niños ‘Ricardo Gutierrez’, and bInstituto de Biología y Medicina Experimental, Buenos Aires, Argentina
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: August 22, 1988
Accepted: January 11, 1989
Published online: April 02, 2008
Issue release date: 1989
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Abstract
Flutamide is a nonsteroidal antiandrogen that blocks androgen receptors, with a consequent increase in serum immunoreactive LH (I-LH) in the presence of high testosterone concentrations. Several studies suggested that the gonadal steroids also play an important role in the regulation of LH bioactivity (B-LH). Therefore, it seems difficult to understand how the blockade of pituitary androgen receptors leads to the increase in testosterone levels. The present study was designed to elucidate the effect of flutamide on serum I-LH, B-LH and testosterone, as well as on in vitro stimulation of pituitaries by gonadotropin-releasing hormone (GnRH), in intact and androgen-treated castrated rats. In intact animals, a dose of flutamide as low as 0.5 mg/day provoked a 7- to 8-fold increase in serum I-LH levels over the vehicle-injected controls, whereas B-LH and testosterone were unaffected. However, higher doses significantly increased serum B-LH to values similar to those obtained in vehicle-injected castrated animals, resulting in high testosterone levels. Flutamide treatment provoked a decrease in I-LH and B-LH pituitary content; this effect was significantly higher under in vitro GnRH stimulation. The releasable I-LH under GnRH stimulation was not affected by flutamide treatment; however, a marked decrease was observed in B-LH. The results presented here show that (1) the interference of androgen action by flutamide is as efficient as castration to affect I-LH and B-LH; (2) androgens may act directly at the pituitary level; (3) androgens modulate the action of GnRH in the pituitary gland, and (4) the effect of androgens on the pituitary can be observed at two distinct levels, depending on the androgen concentration, that is on LH synthesis and release, and on LH bioactivity. In addition, our results confirm that high doses of flutamide are not enough to abolish the biological action of androgens, due to the increase in LH bioactivity resulting in high androgen concentrations.
© 1989 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: August 22, 1988
Accepted: January 11, 1989
Published online: April 02, 2008
Issue release date: 1989
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
